277 related articles for article (PubMed ID: 2526848)
41. In vitro studies on the influence of doxorubicin in combination with recombinant interferon-gamma on human monocytes.
Van Schie RC; De Mulder PH; Verstraten HG; Van Rennes H; Wagener DJ
Anticancer Res; 1991; 11(3):1245-52. PubMed ID: 1832272
[TBL] [Abstract][Full Text] [Related]
42. Effect of rIFN-gamma on antibody-mediated cytotoxicity via human monocyte IgG Fc receptor II (CD32).
van Schie RC; Verstraten HG; Tax WJ; van den Berkmortel FW; van de Winkel JG; de Mulder PH
Scand J Immunol; 1992 Sep; 36(3):385-93. PubMed ID: 1387726
[TBL] [Abstract][Full Text] [Related]
43. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
45. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
46. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies.
Lubeck MD; Kimoto Y; Steplewski Z; Koprowski H
Cell Immunol; 1988 Jan; 111(1):107-17. PubMed ID: 3338092
[TBL] [Abstract][Full Text] [Related]
47. In vitro induction of swine peripheral blood monocyte proliferation by the fibroblast-derived murine hematopoietic growth factor CSF-1.
Genovesi EV; Knudsen RC; Gerstner DJ; Card DM; Martins CL; Quintero JC; Whyard TC
Vet Immunol Immunopathol; 1989 Dec; 23(3-4):223-44. PubMed ID: 2697960
[TBL] [Abstract][Full Text] [Related]
48. Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein.
Nishioka Y; Sone S; Heike Y; Hamada H; Ariyoshi K; Tsuruo T; Ogura T
Jpn J Cancer Res; 1992 Jun; 83(6):644-9. PubMed ID: 1353755
[TBL] [Abstract][Full Text] [Related]
49. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
[TBL] [Abstract][Full Text] [Related]
50. Photometric assays for FcRI-dependent binding, phagocytosis, and antibody-dependent cellular cytotoxicity mediated by monomeric IgG gamma 2a in murine peritoneal macrophages.
Leu RW; Robinson CJ; Wiggins JA; Shannon BJ; Rummage JA; Horn MJ
J Immunol Methods; 1988 Oct; 113(2):269-78. PubMed ID: 2971739
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of immunoglobulin (Ig)G-Fc-mediated cytotoxicity by seminal plasma IgG-Fc receptor III antigens.
Thaler CJ; McConnachie PR; McIntyre JA
Fertil Steril; 1992 Jan; 57(1):187-92. PubMed ID: 1530924
[TBL] [Abstract][Full Text] [Related]
52. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Varney ML; Olsen KJ; Mosley RL; Singh RK
J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
[TBL] [Abstract][Full Text] [Related]
53. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity.
Heike Y; Sone S; Yano S; Seimiya H; Tsuruo T; Ogura T
Int J Cancer; 1993 Jul; 54(5):851-7. PubMed ID: 8100809
[TBL] [Abstract][Full Text] [Related]
54. Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.
Vaickus L; Biddle W; Cemerlić D; Foon KA
Blood; 1990 Jun; 75(12):2408-16. PubMed ID: 2140949
[TBL] [Abstract][Full Text] [Related]
55. Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
Jewett A; Bonavida B
Clin Immunol Immunopathol; 1990 Feb; 54(2):192-9. PubMed ID: 2104787
[TBL] [Abstract][Full Text] [Related]
56. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
Wang M; Friedman H; Djeu JY
J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
[TBL] [Abstract][Full Text] [Related]
58. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface.
Graziano RF; Fanger MW
J Immunol; 1987 Feb; 138(3):945-50. PubMed ID: 2949010
[TBL] [Abstract][Full Text] [Related]
59. Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.
Munn DH; Cheung NK
Prog Clin Biol Res; 1991; 366():389-94. PubMed ID: 2068153
[No Abstract] [Full Text] [Related]
60. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
